A randomized controlled study on perioperative treatment of esophageal squamous cell carcinoma with camrelizumab combined with nab-paclitaxel and cisplatin

被引:0
|
作者
Qi, Yu
Yang, Yang
Li, Weihao
Yue, Songwei
Ma, Yihui
Liu, Donglei
He, Zhanfeng
Chen, Lidong
Li, Wencai
Li, Linghua
Zhao, Song
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Zhengzhou, Peoples R China
[3] Jiangsu Hengrui Med Co Ltd, Lianyungang, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e16075
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Neoadjuvant camrelizumab combined with paclitaxel and nedaplatin for locally advanced esophageal squamous cell carcinoma: a single-arm phase 2 study (cohort study)
    Yang, Yingnan
    Zhang, Jinfeng
    Meng, Hongxue
    Ling, Xiaodong
    Wang, Xiaoyuan
    Xin, Yanzhong
    Jiang, Hao
    Zhang, Luquan
    Fang, Chengyuan
    Liang, Hao
    Ma, Jianqun
    Zhu, Jinhong
    INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (03) : 1430 - 1440
  • [33] A Phase II Study of Concurrent Chemoradiotherapy With Paclitaxel and Cisplatin for Inoperable Esophageal Squamous Cell Carcinoma
    Tang, Hua-Rong
    Ma, Hai-Feng
    An, Shi-Min
    Badakhshi, Harun
    Deng, Jia-Ying
    Zhang, Jun-Hua
    Chen, Yun
    Zhang, Zhen
    Guo, Xiao-Mao
    Jiang, Guo-Liang
    Zhao, Kuai-Le
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2016, 39 (04): : 350 - 354
  • [34] A Randomized Controlled Phase II Study of Nab-Paclitaxel vs. Paclitaxel plus Cisplatin in Concomitant Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
    Yang, W., Sr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E78 - E78
  • [35] Phase 1 study of nab-paclitaxel, cisplatin and 5-fluorouracil as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced squamous cell carcinoma of the oropharynx
    Loong, H. H.
    Winquist, E.
    Waldron, J.
    Chen, E. X.
    Kim, J.
    Palma, D.
    Read, N.
    Razak, A. R. A.
    Diaz-Padilla, I.
    Chan, K.
    Bayley, A.
    Hossain, M.
    Wang, L.
    Chin, S.
    Siu, L. L.
    Hope, A.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (13) : 2263 - 2270
  • [36] Phase I Study of Nab-paclitaxel, Cisplatin and Cetuximab with Concurrent Radiation Therapy for Local-regionally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)
    Nedzi, L. A.
    Sumer, B.
    Myers, L.
    Truelson, J.
    Hughes, R.
    Young, G.
    Barker, J.
    Yao, M.
    Choy, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S440 - S440
  • [37] Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study
    Su Jin Lee
    Sungmin Kim
    Moonjin Kim
    Jeeyun Lee
    Yeon Hee Park
    Young-Hyuck Im
    Se Hoon Park
    BMC Cancer, 15
  • [38] Capecitabine in combination with either cisplatin or weekly paclitaxel as a first-line treatment for metastatic esophageal squamous cell carcinoma: a randomized phase II study
    Lee, Su Jin
    Kim, Sungmin
    Kim, Moonjin
    Lee, Jeeyun
    Park, Yeon Hee
    Im, Young-Hyuck
    Park, Se Hoon
    BMC CANCER, 2015, 15
  • [39] Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302
    Yosuke Kawashima
    Toshiyuki Harada
    Yuka Fujita
    Taku Nakagawa
    Kana Watanabe
    Naoto Morikawa
    Kei Takamura
    Kenya Kanazawa
    Tomoya Kuda
    Kazuhiro Usui
    Akimasa Sekine
    Akira Inoue
    Shunichi Sugawara
    International Journal of Clinical Oncology, 2021, 26 : 515 - 522
  • [40] Toxic epidermal necrolysis during camrelizumab treatment for esophageal squamous cell carcinoma
    Peng, Yuan
    Yu, Qian
    Zhang, Xiaoyue
    Zeng, Chuan
    Zhou, Yan
    Huang, Yusheng
    Yang, Zhenzhou
    CONTACT DERMATITIS, 2022, 86 (05) : 417 - 419